# Toward dysfunctional brain circuitry in schizophrenia and alcohol use disorder: A preclinical neuroimaging study

> **NIH NIH F31** · DARTMOUTH-HITCHCOCK CLINIC · 2021 · $39,893

## Abstract

ABSTRACT
Rates of alcohol use disorder (AUD) are significantly higher in patients with schizophrenia (SCZ) compared to
the general population. My primary mentor (Dr. Alan I. Green) has developed a theoretical neurobiological
formulation suggesting that dysfunctional “brain reward circuity” underpins increased substance use (including
alcohol use) in SCZ, and that such substances may at least partially ameliorate this dysfunction. Supporting this
theory, studies assessing resting-state functional connectivity (rs-fc) via magnetic resonance imaging have
shown that patients with SCZ and co-occurring cannabis use disorder show dysfunctional connectivity between
the nucleus accumbens (NAc) and prefrontal cortical (PFC) regions (NAc-PFC), as well as between the default
mode network (DMN) and the executive control network (ECN). In line with the theory, these circuit dysfunctions
are partially ameliorated by smoking cannabis, but it is currently unknown whether alcohol would have the same
effect in patients with SCZ and AUD. Furthermore, while clinical studies show that the antipsychotic drug
clozapine decreases alcohol use in patients with SCZ, direct evidence of clozapine’s effect on dysfunctional
neural circuitry in SCZ is currently lacking. Here, I propose to use the neonatal ventral hippocampal lesion
(NVHL) rat model to investigate the brain circuit underpinnings of SCZ and AUD. NVHL rats exposed to alcohol
in adolescence (NVHL-AE) drink more alcohol in adulthood compared to sham (control) rats, and their alcohol
intake is reduced by clozapine treatment. Preliminary data suggests that NVHL-AE rats have reduced NAc-PFC
connectivity (similar to what is observed clinically in patients with SCZ), but whether these rats have DMN-ECN
dysfunction is unknown. It is also unknown how either alcohol or clozapine will alter brain connectivity in the
NVHL-AE rat. This F31 proposal, which assesses rs-fc in the NVHL-AE rat, will: 1) confirm NAc-PFC dysfunction;
2) determine if there is dysfunctional DMN-ECN connectivity; and 3) determine the effect of alcohol or clozapine
on connectivity in this animal model. Data from the proposed aims will help assess whether dysfunctional brain
circuitry underpins increased alcohol use in a rodent model used to study SCZ and AUD and, whether alcohol
exposure or clozapine treatment will at least partially ameliorate some of the circuit dysfunction. These studies
will be impactful because they will test the relationship of candidate biomarkers of connectivity (dysfunctional
NAc-PFC and/or DMN-ECN connectivity) and increased alcohol use in SCZ. The results generated from these
Aims will lay the groundwork for future investigations in which dysfunctional connectivity is selectively targeted
to develop novel treatments for SCZ and AUD. Completion of these studies will allow me to apply my training in
advanced neuroimaging and analytic techniques and, by doing so, prepare me to address important questions
in the field of co-occurri...

## Key facts

- **NIH application ID:** 10254282
- **Project number:** 5F31AA028413-02
- **Recipient organization:** DARTMOUTH-HITCHCOCK CLINIC
- **Principal Investigator:** Emily Sullivan
- **Activity code:** F31 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $39,893
- **Award type:** 5
- **Project period:** 2020-09-01 → 2022-06-10

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10254282

## Citation

> US National Institutes of Health, RePORTER application 10254282, Toward dysfunctional brain circuitry in schizophrenia and alcohol use disorder: A preclinical neuroimaging study (5F31AA028413-02). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10254282. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*